Trazodone HCL Tablets
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D2-21-D-0137
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents2
The Defense Logistics Agency (DLA) Troop Support, a federal office, has issued an award notice for a firm fixed price requirements contract pertaining to the supply of Trazodone Hydrochloride (HCL) tablets. This procurement is classified under NAICS Code 325412, which covers Pharmaceutical Preparation Manufacturing, and is further identified by Product Service Code 6505, indicating a focus on drugs and biologicals.
The scope of this contract encompasses the provision of Trazodone HCL tablets in multiple dosage strengths and packaging configurations to meet the ongoing needs of the agency. Specifically, the contract covers:
- Trazodone HCL Tablets 50MG, available in bottles containing either 90 or 1,000 tablets
- Trazodone HCL Tablets 100MG, also in 90 and 1,000 count bottles
- Trazodone HCL Tablets 150MG, supplied in bottles of 90 and 500 tablets
The intended outcome of this procurement is to ensure a reliable and consistent supply of these pharmaceutical products for federal requirements, supporting the health and readiness of personnel served by DLA Troop Support. The contract is structured as a firm fixed price requirements agreement, which provides price stability and clear expectations for both the agency and the supplier over the contract lifecycle.
This opportunity was competed under full and open competition, inviting qualified manufacturers and suppliers to participate. There are no set-aside requirements or special considerations indicated in the notice, suggesting that the procurement was accessible to all eligible entities within the pharmaceutical manufacturing sector.
The contracting entity, DLA Troop Support, is responsible for managing the acquisition and distribution of medical supplies for federal agencies. Interested parties or current contractors may direct inquiries to the primary contact, Kevin Rafferty ([email protected], 215-737-0907), or the secondary contact, Denise Taubman ([email protected], 215-737-8677), for further information regarding contract administration or ongoing requirements.
Additional details, including attachments related to the award, can be accessed via the official notice on SAM.gov at https://sam.gov/opp/d71f962d736f40e2bff3b14d94554af7/view. The notice remains active as of the posting date, July 14, 2022.
This contract represents a stable and ongoing opportunity for pharmaceutical manufacturers specializing in generic drug production, particularly those with capabilities in producing and packaging Trazodone HCL tablets in the specified dosages and quantities. The requirements and objectives outlined are expected to remain consistent throughout the duration of the contract, ensuring clarity and predictability for all parties involved.